Sign in

CIK 0001099800

  • Large accelerated filer

Edwards Lifesciences Corp

Sign in to watch
Ticker
EW
Exchange
NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364316614
Phone
+1 949-250-2500
Business address
ONE EDWARDS WAY, IRVINE, CA, 92614
Former names
CVG CONTROLLED INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$10,886,105
in 9 filings, $7.6M under 10b5-1 plans

Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-23 GALLAHUE KIERAN Director Gift −7,056 3,701
2024-02-23 GALLAHUE KIERAN Director Gift +7,056 70,277
2024-02-23 GALLAHUE KIERAN Director Sale −3,058 $87.61 $268K 67,219
2024-02-23 GALLAHUE KIERAN Director Exercise or conversion · Director Stock Option (Right to Acquire) −7,056 0
2024-02-22 SELLERS ROBERT W.A. SVP, Corporate Controller Grant or award +1,998 15,085.18
2024-02-22 Szyman Catherine M. CVP, Critical Care Grant or award +8,560 43,373.57
2024-02-21 Chopra Daveen CVP, TMTT Exercise or conversion +7,000 $59.26 $415K 30,950
2024-02-21 Chopra Daveen CVP, TMTT Sale −1,200 $86.67 $104K 29,750
2024-02-21 Chopra Daveen CVP, TMTT Sale −7,000 $86.75 $607K 22,750
2024-02-21 Chopra Daveen CVP, TMTT Exercise or conversion · Employee Stock Option (Right to Acquire) −7,000 0
2024-02-18 Lippis Daniel J. CVP, JAPAC Shares withheld for taxes −188 $86.10 $16K 17,213.21
2024-02-17 Lippis Daniel J. CVP, JAPAC Shares withheld for taxes −150 $86.10 $13K 17,401.21
2024-02-16 Lippis Daniel J. CVP, JAPAC Shares withheld for taxes −207 $86.04 $18K 17,551.21
2024-02-16 Ullem Scott B. CVP, Chief Financial Officer Shares withheld for taxes −174 $86.04 $15K 19,074
2024-02-16 Wood Larry L Global President TAVR & Surg Shares withheld for taxes −317 $86.04 $27K 213,476.71
2024-02-15 Szyman Catherine M. CVP, Critical Care Exercise or conversion +27,000 $36.75 $992K 61,813.57
2024-02-15 Szyman Catherine M. CVP, Critical Care Sale −27,000 $85.62 $2.3M 34,813.57
2024-02-15 Szyman Catherine M. CVP, Critical Care Exercise or conversion · Employee Stock Option (Right to Acquire) −27,000 0
2024-02-13 Szyman Catherine M. CVP, Critical Care Exercise or conversion +20,000 $36.75 $735K 54,813.57
2024-02-13 Szyman Catherine M. CVP, Critical Care Sale −20,000 $86.46 $1.7M 34,813.57

Page 29 of 43 · 841 trades